Carta al Editor
Leishmaniasis cutánea: a propósito de un caso en el contexto del tratamiento con adalimumab
Cutaneous Leishmaniasis: A Case Study in the Context of Treatment with Adalimumab
Leído
8055
Vecesse ha leído el artículo
1458
Total PDF
6597
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 8 | 1 | 9 |
| 2025 5 | 236 | 40 | 276 |
| 2025 4 | 198 | 32 | 230 |
| 2025 3 | 308 | 30 | 338 |
| 2025 2 | 250 | 27 | 277 |
| 2025 1 | 133 | 46 | 179 |
| 2024 12 | 107 | 33 | 140 |
| 2024 11 | 112 | 58 | 170 |
| 2024 10 | 155 | 34 | 189 |
| 2024 9 | 172 | 19 | 191 |
| 2024 8 | 174 | 30 | 204 |
| 2024 7 | 280 | 29 | 309 |
| 2024 6 | 127 | 41 | 168 |
| 2024 5 | 98 | 24 | 122 |
| 2024 4 | 86 | 23 | 109 |
| 2024 3 | 154 | 32 | 186 |
| 2024 2 | 197 | 33 | 230 |
| 2024 1 | 205 | 27 | 232 |
| 2023 12 | 247 | 22 | 269 |
| 2023 11 | 312 | 37 | 349 |
| 2023 10 | 300 | 31 | 331 |
| 2023 9 | 309 | 28 | 337 |
| 2023 8 | 231 | 33 | 264 |
| 2023 7 | 161 | 25 | 186 |
| 2023 6 | 141 | 30 | 171 |
| 2023 5 | 109 | 41 | 150 |
| 2023 4 | 69 | 17 | 86 |
| 2023 3 | 186 | 23 | 209 |
| 2023 2 | 148 | 20 | 168 |
| 2022 1 | 160 | 16 | 176 |
| 2022 12 | 119 | 32 | 151 |
| 2022 11 | 125 | 42 | 167 |
| 2022 10 | 142 | 41 | 183 |
| 2022 9 | 118 | 34 | 152 |
| 2022 8 | 104 | 45 | 149 |
| 2022 7 | 115 | 41 | 156 |
| 2022 6 | 73 | 44 | 117 |
| 2022 5 | 75 | 27 | 102 |
| 2022 4 | 64 | 56 | 120 |
| 2022 3 | 68 | 47 | 115 |
| 2022 2 | 56 | 36 | 92 |
| 2021 1 | 52 | 46 | 98 |
| 2021 12 | 48 | 32 | 80 |
| 2021 11 | 39 | 41 | 80 |
| 2021 10 | 6 | 4 | 10 |
| 2021 9 | 2 | 0 | 2 |
| 2021 7 | 2 | 0 | 2 |
| 2021 6 | 1 | 2 | 3 |
| 2021 5 | 4 | 2 | 6 |
| 2021 4 | 5 | 2 | 7 |
| 2021 3 | 1 | 0 | 1 |
| 2021 2 | 1 | 0 | 1 |
| 2020 1 | 1 | 0 | 1 |
| 2020 7 | 1 | 0 | 1 |
| 2020 6 | 2 | 2 | 4 |
Mostrar todo
